EUVIMEDEUVIMED entdecken
Crossref

Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway

Miaohua Liu, Fuchun Liu, Yuanle Pan, Yi Xiong, Xin Zeng, LinXin Zheng, Haimei Zhao, Yanzhen Li, Duanyong Liu

International Immunopharmacology · 2023-02 · 115 · 109612

DOI: 10.1016/j.intimp.2022.109612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-02. Verfasst von Miaohua Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Postgraduate, Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi Province, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is common knowledge that the crosstalk of gut microbiota (GM) and dendritic cells (DCs) are critical for the pathogenesis of inflammatory bowel disease (IBD). As a major bioactive constituent derived from the root of the Sophora flavescens, Oxymatrine (OMT) was used to treat IBD in China. However, it is still unknown whether OMT ameliorates IBD by regulating the crosstalk between DCs and GM. In the present study, after 10 days of OMT (100 mg/kg/day) treated mice with colitis induced by dextran sulfate sodium (DSS), the change rate of body weight, colon weight, colon weight index, colon length, DAI score and colonic pathological damage scores of colitis mice were significantly ameliorate, followed with fewer ulceration and inflammatory cell infiltration, the increased expression of IL-4 and IL-13, and the decreased expression of CCL-2, IL-33 and IFN-γ. The percents of inflammatory DCs (such as TNF-α+DCs, iNOS+DCs, CXCR5+DCs and E-cadherin+DCs) were markedly decreased, and the GM composition was regulated. Importantly, it is positive correlated between the efficacy of OMT on colitis, GM and inflammatory DCs. Meanwhile, Western blotting assay showed that OMT suppressed the activation of TLR4, Myd88, IRAK4, IRAK1, TRAF6, TAK1, TAB, MKK3, MKK6, P38, NF-κB in the TLR / NF-κB signaling pathway. In summary, OMT exhibits the protective effect against the DSS-induced experimental colitis, which was achieved by regulating the crosstalk of inflammatory DCs and GM, and inhibiting the TLR / NF-κB signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColitisInflammatory Bowel DiseasesAnimalsMiceNF-kappa BColonDextran SulfateDisease Models, AnimalMice, Inbred C57BLMatrines

Stichwörter der Autor:innen

Dendritic cellsDextran sodium sulfateGut microbiotaInflammatory bowel diseaseOxymatrine

Substanzen

NF-kappa BDextran SulfateoxymatrineMatrines

Autor:innen und Institutionen

  • Department of Postgraduate, Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi Province, China.
  • College of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi Province, China.
  • Nanchang Medical College, Nanchang 330004, Jiangxi Province, China. Electronic address: 277259408@qq.com.
  • Formula-Pattern Research Center of Jiangxi University of Chinese Medicine, Nanchang 330004, Jiangxi Province, China. Electronic address: liuduanyong@163.com.

Zitieren

APA

Liu, M., Liu, F., Pan, Y., Xiong, Y., Zeng, X., Zheng, L., Zhao, H., Li, Y., & Liu, D. (2023). Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway. International Immunopharmacology, 115, 109612. https://doi.org/10.1016/j.intimp.2022.109612

Vancouver

Liu M, Liu F, Pan Y, Xiong Y, Zeng X, Zheng L, et al. Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway. International Immunopharmacology. 2023;115:109612. doi:10.1016/j.intimp.2022.109612

BibTeX
@article{Liu2023,
  author = {Liu, Miaohua and Liu, Fuchun and Pan, Yuanle and Xiong, Yi and Zeng, Xin and Zheng, LinXin and Zhao, Haimei and Li, Yanzhen and Liu, Duanyong},
  title = {Oxymatrine ameliorated experimental colitis via mechanisms involving inflammatory DCs, gut microbiota and TLR/NF-κB pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {115},
  pages = {109612},
  doi = {10.1016/j.intimp.2022.109612}
}
Kostenlos starten →